Simon Lord was diagnosed with prostate cancer at the age of 50. Fortunately, it was found at an early stage and successfully treated. His experience with prostate cancer inspired him to make changes in his career, and his approach offers inspiration to others facing a difficult diagnosis.
Results of Health Union’s Asthma In America 2019 and COPD In America 2019 show that nearly half of each surveyed population are highly interested in using a digital inhaler.
Cindy “Myeloma Teacher” Chmielewski has been living with multiple myeloma, a form of blood cancer, since 2008. In our podcast interview, she spoke about her path to diagnosis, the value of being an empowered patient, and how she continues to live life at the edge of her comfort zone.
Alisha Bridges has been living with psoriasis since childhood, and in this podcast interview, she shares how she navigated growing up with the added the challenges of psoriatic disease. She has found strength and confidence through her experience, and she now helps others through her volunteer and advocacy work.
How does living with a chronic condition impact dating? Hear from four Health Union contributors as they share the joys & challenges of dating while living with a chronic condition.
Results of Health Union’s Endometriosis In America 2019 survey of more than 1,200 women diagnosed with endometriosis reveal nearly four in 10 have tried five or more different hormone therapies in an attempt to better manage their condition.
Jill Feldman & Ivy Elkins are contributors and advocates on LungCancer.net. Both women have been living with lung cancer for many years.
People living with chronic conditions are gravitating more towards streaming services than cable TV because of the desire to watch on their own terms. When considering where to spend your pharma marketing dollars, does your strategy account for these changing habits?
Cora Lyn Sears talks about diagnosis and treatment for macular degeneration, the leading cause of vision loss in the U.S.
Key findings from a joint survey conducted by Health Union and BBK Worldwide – featuring perspectives from pharmaceutical and biotechnology sponsors, physicians, and patients – challenge the long-held notion that physicians are reluctant to refer their patients to other specialists for access to clinical trials.